A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers-Reference-Cited by-同舟云学术

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

Published:2016-11-16 Issue:1 Volume:35 Page:95-104
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Goff Laura W.,Cardin Dana B.,Whisenant Jennifer G.,Du Liping,Koyama Tatsuki,Dahlman Kimberly B.,Salaria Safia N.,Young Ruth T.,Ciombor Kristen K.,Gilbert Jill,Smith Stephen James,Chan Emily,Berlin Jordan

Funder

National Cancer Institute

Astellas Pharma US

Vanderbilt-Ingram Cancer Center

T.J. Martell Foundation

Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-016-0406-z.pdf

Reference43 articles.

1. American Cancer Society. Cancer Facts & Figures (2016) 2016. Atlanta, American Cancer Society

2. Anderson CD, Pinson CW, Berlin J, Chari RS (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9(1):43–57

3. Gebbia V, Giuliani F, Maiello E, Colucci G, Verderame F, Borsellino N, Mauceri G, Caruso M, Tirrito ML, Valdesi M (2001) Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19(20):4089–4091

4. Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, Selle F, Paye F, Hannoun L, Houry S, Gayet B, JP L, de Gramont A, Louvet C, Group G (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15(9):1339–1343. doi: 10.1093/annonc/mdh351

5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies;Cancers;2023-06-23

2. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma;Cancers;2022-02-17

3. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma;Medical Oncology;2020-11

4. Piperlongumine induces autophagy in biliary cancer cells via�reactive oxygen species-activated Erk signaling pathway;International Journal of Molecular Medicine;2019-08-23

5. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance;Liver International;2019-05